GP2
GP2 Posts Eighth Data Release
Learn MoreGP2 announces its eighth data release which includes 5,481 additional whole genome sequences and 10,454 clinical exome sequences.
GP2 Launches Funded Master’s Programs for Underrepresented Populations
Learn MoreGP2 is partnering with UCL and UCMB and offers funding for physicians and scientists from underrepresented populations to pursue master's degrees in PD related…
GP2 Posts Sixth Data Release
Learn MoreHighlights include the introduction of a new ancestry group (Complex Admixture History), the introduction of clinical data for ~12,000 individuals, and the int…
Parkinson’s Gene Found in Africa With Funding From Sergey Brin
Learn MoreHere Bloomberg journalist Robert Langreth highlights the impact GP2’s GBA1 finding has on the future of genetic disease studies.
Gene Variant Found Linking People of African Descent to Higher Parkinson’s Risk
Learn MoreWatch Ekemini Riley, ASAP’s Managing Director discuss the importance of GP2’s discovery and approach on PBS’s NewsHour.
GP2 Cohort Dashboard Now Includes New Ancestry Categories
Learn MoreThe updated GP2 Cohort dashboard now includes additional ancestry information across cohort samples that have already been processed and shared with the AMP PD…
Expanded Data Available on GP2’s Updated Cohort Dashboard
Learn MoreThe new cohort dashboard provides a real-time look at each cohort within the GP2 network, including location data, number of samples for genotyping, and an anc…
Explore the Monogenic Portal
Learn MoreThe Monogenic Portal gives researchers from around the globe a platform for sharing samples and key insights. Insights are focused on the studying early-onset …
GP2 Announces First Data Release
Learn MoreGP2 is excited to announce, in collaboration with AMP® PD, our first data release. It consists of 4,908 participants from multiple cohorts.
GP2 Launches Interactive Dashboard
Learn MoreExplore this tool to see our progress collecting diverse cohorts from around the world (updated quarterly).
First-of-its-Kind DNA Biobank Opens in Peru
Learn MoreASAP, through GP2 and in partnership with LARGE-PD and the MJFF, celebrated a shared milestone with the inauguration of the DNA Biobank at the Instituto Nacion…
Researching Parkinson’s disease genetics on a global scale
Learn MoreThis Movement Disorders article explores GP2's ambitions to facilitate the rapid expansion of our understanding of the genetic architecture of PD, both in term…
Black and African American Connections to PD
Learn MoreGP2 launched BLAAC PD: Black and African American Connections to Parkinson’s Disease, as part of our commitment to increase representation in research and care…
GP2 Opportunities
Learn MoreDevelopment is an important component of our program; our focus is to provide training and other funding opportunities for the next generation of Parkinson’s d…
Introduction to GP2
Learn MoreIn the first GP2 blog post, Andrew Singleton, NIH Distinguished Investigator and GP2 Lead, introduces the program's aims, values and vision.
Introducing the GP2 Learning Platform
Learn MoreTraining is central to the GP2 effort. Visit our learning platform for training on topics related to Parkinson’s disease genetics.
GP2-funded PhD Studentship
Learn MoreBased at UCL, the PhD will involve collaboration with world leaders in PD genetics across the GP2 network. The application deadline is August 31, 2020.
ASAP Announces Global Parkinson’s Genetics Program to Genotype 150,000 Volunteers
Learn MoreGlobal Parkinson's Genetics Program (GP2) will support the ongoing search for new genetic determinants of Parkinson's disease in diverse populations.